SBI Symposium Collection: Crack the Case: Breast MRI & CEM

SBI Symposium Collection: Crack the Case: Breast MRI & CEM

Contrast enhanced mammography (CEM) and breast magnetic resonance imaging (MRI) are contrast-enhanced advanced breast imaging modalities that many radiologists find challenging to interpret. Indeed, surveyed attendees of the 2023 SBI Symposium request breast MRI and CEM as the top two breast imaging modalities for continuing education.  This highlights the need for additional educational activities to review the application and diagnostic challenges in the detection and characterization of breast malignancies at CEM and breast MRI. This collection features presentations from the 2023 SBI Symposium.

Breast MRI & CEM Lectures

1) Crack the Case: Abbreviated and Full Protocol MRI Cases

Speakers:

• Christopher Comstock, MD, FSBI
• Katerina Dodelzon, MD, FSBI
• Bonnie N. Joe, MD, FSBI

2) CEM: Doing It, Reading It, Reporting It

Speakers:

• Jordana Phillips, MD, FSBI 
• Priscilla Slanetz, MD, FSBI
• Janice Sung, MD, FSBI

3) Crack the Case: Challenging Multimodality Cases

Speakers:

• Beatriz Adrada, MD, FSBI
• Debra Ikeda, MD, FSBI
• Ana Lourenco MD, FSBI

Learning Objectives:

• Compare the performance of abbreviated breast MRI (AB-MRI) to full protocol breast MRI.
• Apply the CEM BI-RADS lexicon in characterizing various CEM findings.
• Identify the essential components of a contrast enhanced mammography (CEM) program.
• Differentiate between breast cancer recurrence and benign post-operative change following breast reconstruction.
• Identify and appropriately characterize breast malignancies, benign breast disease, and background parenchymal enhancement at breast MRI.

CME Released:  1/16/2024   CME Expires:  1/15/2027

Location: Online

Joint Accreditation Statement - In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging . Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163

Physicians - Amedco LLC designates this material for a maximum of 3.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learner Notification:

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging . Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Professions in scope for this activity are listed below.

Amedco Joint Accreditation Provider Number: 4008163

Physicians - Amedco LLC designates this material for a maximum of 3.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

Name - Commercial Interest: Relationship

Beatriz Adrada- NA

Christopher Comstock- Bayer Medial, Hologic Inc:Scientific/Medical Advisory Board Member, Guerbet Inc:Consultant, Bracco Diagnostics Inc, GE Medical:Speakers Bureau

Katerina Dodelzon- NA

Bonnie Joe- Kheiron Medical Technologies:Research Grant Site Principal Investigator

Ana Lourenco- NA

Jordana Phillips- GE Healthcare, Hologic:ConsultantJanice Sung -NA

Nuria Gramkee- NARyan Dixon- NA